Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Oct 25;7(1):13976.
doi: 10.1038/s41598-017-14481-y.

Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study

Affiliations
Observational Study

Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study

Elaine Rutherford et al. Sci Rep. .

Abstract

Patients commencing on haemodialysis (HD) have an increased risk of cardiovascular events in the first year after starting HD compared to those patients established on HD longer. Left ventricular (LV) hypertrophy and abnormal myocardial strain predict mortality. There may be changes in the myocardium of incident HD patients over a 6-month period of HD which may explain changes in cardiovascular risk. We used CMR to consider changes in LV mass, myocardial strain and T1 mapping. We examined changes in pre-dialysis highly sensitive troponin T. 33 patients undergoing HD for <12 months were recruited. Participants underwent CMR at baseline and after 6-months of standard care. 6-months of HD was associated with reduction in LV mass index (Baseline: 78.8 g/m2 follow up: 69.9 g/m2, p = <0.001). LV global longitudinal strain also improved (Baseline: -17.9%, follow up: -21.6%, p = <0.001). Change in T1 time was not significant (Baseline septal T1 1277.4 ms, follow up 1271.5 p = 0.504). Highly sensitive troponin T was lower at follow up (Baseline 38.8 pg/L, follow up 30.8 pg/L p = 0.02). In incident HD patients, 6-months of HD was associated with improvements in LV mass, strain and troponin. These findings may reflect improvement in known cardiac tissue abnormalities found in patients over the first year of HD.

PubMed Disclaimer

Conflict of interest statement

The University of Glasgow has a research agreement with Siemens Healthcare UK. No author has any conflict of interest to declare.

Figures

Figure 1
Figure 1
Box plot of Left Ventricular Mass Index at baseline and follow up.
Figure 2
Figure 2
Scatter plots of Left Ventricular Mass Index and Global longitudinal strain at baseline and follow-up.
Figure 3
Figure 3
Typical changes in a study participant whose cardiac parameters improved over the duration of the study. Panels A–C are baseline images, panels D–F are follow up images. Panel A shows a short axis view of the left ventricle on baseline imaging, the myocardial thickness measures 1.7 cm, by follow up (panel D) the diameter had reduced to 1.4 cm. Panel B shows a typical T1 map obtained during the study, an interventricular septal segment has been drawn on and shows a T1 time of 1294 ms, by follow up (panel E) the corresponding segment had a noticeable reduction in T1 time to 1211 ms. Panel C shows a representative graph of global longitudinal strain; the horizontal axis is time throughout the cardiac cycle and the vertical axis shows amount of myocardial displacement. On comparison of panel C with panel F the displacement is greater in panel F, representing an improvement in myocardial strain mechanics over the study follow up period.

References

    1. Foley RN, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–192. doi: 10.1038/ki.1995.22. - DOI - PubMed
    1. Foley RN, et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J. Am. Soc. Nephrol. 1995;5:2024–31. - PubMed
    1. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286–290. doi: 10.1038/ki.1989.192. - DOI - PubMed
    1. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol. Dial. Transplant. 1990;5:39–44. doi: 10.1093/ndt/5.1.39. - DOI - PubMed
    1. Foley R, Parfrey P, Sarnak M. Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases. 1998;32:S112–S119. doi: 10.1053/ajkd.1998.v32.pm9820470. - DOI - PubMed

Publication types